| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,346 |
7,187 |
$550K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,825 |
1,566 |
$160K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,676 |
1,380 |
$139K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,079 |
937 |
$95K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,035 |
3,272 |
$72K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
728 |
658 |
$65K |
| 92587 |
|
2,158 |
1,829 |
$55K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,640 |
2,856 |
$54K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,164 |
1,827 |
$27K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
286 |
221 |
$24K |
| 96127 |
|
1,370 |
1,100 |
$18K |
| 99173 |
|
2,005 |
1,732 |
$11K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
585 |
411 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
724 |
656 |
$6K |
| 87430 |
|
525 |
485 |
$5K |
| 96161 |
|
236 |
230 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
192 |
134 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
280 |
125 |
$2K |
| 36416 |
|
686 |
666 |
$2K |
| 83655 |
|
185 |
182 |
$2K |
| 96160 |
|
76 |
73 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
77 |
33 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
20 |
12 |
$903.33 |
| 0072A |
|
21 |
20 |
$800.00 |
| 87807 |
|
101 |
48 |
$494.88 |
| 0071A |
|
12 |
12 |
$480.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
28 |
28 |
$332.64 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
12 |
12 |
$229.24 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12 |
12 |
$77.00 |
| 85018 |
|
230 |
227 |
$36.54 |
| 90670 |
|
656 |
523 |
$0.00 |
| 90671 |
|
165 |
162 |
$0.00 |
| 90681 |
|
195 |
116 |
$0.00 |
| 90633 |
|
250 |
204 |
$0.00 |
| 90710 |
|
217 |
174 |
$0.00 |
| 90686 |
|
1,273 |
845 |
$0.00 |
| 90697 |
|
255 |
201 |
$0.00 |
| 91307 |
|
69 |
56 |
$0.00 |
| 90698 |
|
252 |
214 |
$0.00 |
| 90744 |
|
66 |
66 |
$0.00 |
| 90674 |
|
629 |
619 |
$0.00 |
| 90378 |
|
13 |
13 |
$0.00 |
| 90651 |
|
12 |
12 |
$0.00 |